Axim Biotechnologies Inc (AXIM)

[TexasMarvL]

Another detail I wanted to share from the 10K.


PAGE 14.
"On February 20, 2024, AXIM announced that Verséa™ Ophthalmics, LLC, placed an order for an additional 50 of IUL Lateral Flow Readers."

ONLY 50 READERS????

I realize $2000 per reader adds up quickly.
50 × $2000 = $100,000.

BUT

If AXIM and Verséa were anywhere close to CLIA Waiver approval, they would not order just 50 readers. If CLIA Waiver is anywhere close to approval there would be an order of 300 or 500 or 1000 readers.

Besides that, according to one post or video some customers are purchasing two readers so they can run both tests concurrently to save time.

Look at AXIM realistically.
This company has a lot of potential and hopefully just a few months down the road.

Keep watching.
Hang on to some dry powder.


About the only things to budge AXIM share price in the short-term is a potential merger or acquisition or a new merchandising agreement for the Parkinsons disease test. I do think AXIM has to consider a merchandising agreement for the Parkinsons disease test because they are bleeding too much cash right now.